Testing effectiveness (Phase 2)UnknownNCT05093140
What this trial is testing
Camrelizumab Plus R-CHOP Regimen in Untreated Primary Extranodal DLBCL
Who this might be right for
Primary Extranodal LymphomaDLBCL
Sun Yat-sen University 30
Showing 20 of 0 results